Atlas Venture Fund X L.P. 13D and 13G filings for Ikena Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 5:12 pm Purchase |
2021-03-30 | 13D | Ikena Oncology, Inc. IKNA |
Atlas Venture Fund X L.P. | 2,901,609 8.100% |
2,901,609 (New Position) |
Filing |